- Home
- ORIC vs LDP Comparison
ORIC vs LDP Comparison
Compare ORIC & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- LDP
- Stock Information
- Founded
- ORIC 2014
- LDP 2012
- Country
- ORIC United States
- LDP United States
- Employees
- ORIC N/A
- LDP N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- ORIC Health Care
- LDP Finance
- Exchange
- ORIC Nasdaq
- LDP Nasdaq
- Market Cap
- ORIC 750.6M
- LDP 607.2M
- IPO Year
- ORIC 2020
- LDP N/A
- Fundamental
- Price
- ORIC $8.50
- LDP $20.90
- Analyst Decision
- ORIC Strong Buy
- LDP
- Analyst Count
- ORIC 9
- LDP 0
- Target Price
- ORIC $18.75
- LDP N/A
- AVG Volume (30 Days)
- ORIC 499.8K
- LDP 102.5K
- Earning Date
- ORIC 11-12-2024
- LDP 01-01-0001
- Dividend Yield
- ORIC N/A
- LDP 7.91%
- EPS Growth
- ORIC N/A
- LDP N/A
- EPS
- ORIC N/A
- LDP N/A
- Revenue
- ORIC N/A
- LDP N/A
- Revenue This Year
- ORIC N/A
- LDP N/A
- Revenue Next Year
- ORIC N/A
- LDP N/A
- P/E Ratio
- ORIC N/A
- LDP N/A
- Revenue Growth
- ORIC N/A
- LDP N/A
- 52 Week Low
- ORIC $6.33
- LDP $16.16
- 52 Week High
- ORIC $16.65
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- ORIC 37.50
- LDP 41.58
- Support Level
- ORIC $10.06
- LDP $20.77
- Resistance Level
- ORIC $11.11
- LDP $21.70
- Average True Range (ATR)
- ORIC 0.81
- LDP 0.28
- MACD
- ORIC -0.05
- LDP -0.02
- Stochastic Oscillator
- ORIC 13.00
- LDP 13.44
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.